Cargando…
Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
Diabetic cardiomyopathy (DCM) is the principal cause of death in people with diabetes. However, there is currently no effective strategy to prevent the development of DCM. Although cyclovirobuxine D (CVB-D) has been widely used to treat multiple cardiovascular diseases, the possible beneficial effec...
Autores principales: | Jiang, Zhaohui, Fu, Lingyun, Xu, Yini, Hu, Xiaoxia, Yang, Hong, Zhang, Yanyan, Luo, Hong, Gan, Shiquan, Tao, Ling, Liang, Guiyou, Shen, Xiangchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156511/ https://www.ncbi.nlm.nih.gov/pubmed/32286474 http://dx.doi.org/10.1038/s41598-020-63498-3 |
Ejemplares similares
-
Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro
por: Gao, Ge, et al.
Publicado: (2022) -
Protective effects of essential oil from Fructus Alpiniae zerumbet on retinal Müller gliosis via the PPAR-γ-p-CREB signaling pathway
por: Yang, Hong, et al.
Publicado: (2020) -
Inhibitory Effects of Oxymatrine on Transdifferentiation of Neonatal Rat Cardiac Fibroblasts to Myofibroblasts Induced by Aldosterone via Keap1/Nrf2 Signaling Pathways In Vitro
por: Yang, Yu, et al.
Publicado: (2019) -
Baicalein inhibits fibronectin-induced epithelial–mesenchymal transition by decreasing activation and upregulation of calpain-2
por: Chen, Yan, et al.
Publicado: (2019) -
Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
por: Guo, Qian, et al.
Publicado: (2015)